Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice

Circulation

Volumn 99, Issue 23, 1999, Pages 3063-3070

  Rohde, Luis E ^a   Ducharme, Anique ^a   Arroyo, Luis H ^a   Aikawa, Masanori ^a   Sukhova, Galina H ^a   Lopez Anaya, Arturo ^b   McClure, Kim F ^b   Mitchell, Peter G ^b   Libby, Peter ^a   Lee, Richard T ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Left ventricle; Metalloproteinases; Myocardial infarction

Indexed keywords

COLLAGEN; CP 471474; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG STRUCTURE; EXTRACELLULAR MATRIX; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE VOLUME; IMAGE ANALYSIS; M MODE ECHOCARDIOGRAPHY; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINASE INHIBITION; TREATMENT OUTCOME;

EID: 0033564775     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.23.3063     Document Type: Article

References (27)

1. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol. 1991; 260:H1406-H1414.
2. White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ. Left ventricular end systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76: 44-51.
3. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990;81:1161-1172.
4. Kostuk WJ, Kazamias TM, Gander MP, Simon AL, Ross J. Left ventricular size after myocardial infarction: serial changes and their prognostic significance. Circulation. 1973;47:1174-1179.
5. Rumberger JA. Ventricular dilatation and remodeling after myocardial infarction. Mayo Clin Proc. 1994;69:664-674.
6. Tyagi SC, Ratajska A, Weber KT. Myocardial matrix metalloproteinases: localization and activation. Mol Cell Biochem. 1993;126:49-59.
7. Cleutjens JPM, Kandala JC, Guarda E, Guntaka RV, Weber KT. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol. 1995;27:1281-1292.
8. Cleutjens JPM, Verluyten MJA, Smits JFM, Daemen MJAP. Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol. 1995;147:325-338.
9. Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley AJ III, Spinale FG. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation. 1998;97:1708-1715.
10. Coker ML, Thomas CV, Clair MJ, Hendrick JW, Kombrach RS, Galis ZS, Spinale FG. Myocardial matrix metalloproteinase activity and abundance with congestive heart failure. Am J Physiol. 1998;274: H1516-H1523.
11. Spinale FG, Krombach RS, Coker ML, Mukherjee R, Houck WV, Clair MJ, Kribbs SB, Hebbar L, Peterson JT. Matrix metalloproteinase inhibition with congestive heart failure improves left ventricular geometry and pump function. Circulation. 1997;96(suppl I):I-520. Abstract.
12. Peterson JT, Rosebury WS, Robertson AW, Washington RA, Li H, O'Brien PM, Sliskovic DR, Hallak H, Uprichard ACG, Bocan TMA. Matrix metalloproteinase inhibition blocks progression of heart failure. Circulation. 1997;96(suppl I):I-520. Abstract.
13. Zolotareva AG, Kogan ME. Production of experimental myocardial infarction in mice. Cor Vasa. 1978;20:308-314.
14. Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, Hawkins HK, Berens K, Ballantyne CM. Myocardial ischemia and reperfusion: a murine model. Am J Physiol. 1995;269:H2147-H2154.
15. Solomon SD, Aikawa Y, Martini MS, Rosario L, Makker G, Gerson D, Greaves S, Lee RT. Assessment of regional left ventricular wall stress following myocardial infarction by echocardiography-based structural analysis. J Am Soc Echocardiogr. 1998;11:938-947.
16. Manning WJ, Wei JY, Katz SE, Douglas PS, Gwathmey JK. Echocardiographically detected myocardial infarction in the mouse. Lab Anim Sci. 1993;43:583-585.
17. Tanaka N, Dalton N, Mao L, Rockman HA, Peterson KL, Gottshall KR, Hunter JJ, Chien KR, Ross JJ. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation. 1996;94:1109-1117.
18. Brilla CG, Pick R, Tan LP, Janicki JS, Weber KT. Remodeling of rat right and left ventricles in experimental hypertension. Circ Res. 1986;58: 38-46.
19. Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, Drexler H. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation. 1994;89:2273-2282.
20. Spinale FG, Thomas CV, Walker JD, Mukherjee, Hebbar L. Time-dependent changes in matrix metalloproteins activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ Res. 1998;82:482-495.
21. Thomas CV, Coker ML, Zelnner JL, Handy JR, Crumbley AJ, Spinale FG. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation. 19998;97:1708-1715.
22. White MB, Thomton FJ, Kiyama T, Efron DT, Schulz GS, Moldawer LL, Barbul A. Metalloproteinase inhibitors and wound healing: a novel enhancer of wound strength. Surgery. 1998;124:464-470.
23. Saarialho-Kere UK, Kovacs SO, Pentland AP, Olerud JE, Welgus HG, Parks WC. Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest. 1993;92:2858-2866.
24. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation. 1985;72:406-412.
25. Vincenti MP, Coon CI, Mengshol JA, Yocum S, Mitchell P, Brinckerhoff CE. Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1). Biochem J. 1998;331:341-346.
26. Kass DA, Hare JM, Georgakopoulos D. Murine cardiac function: a cautionary tail. Circ Res. 1998;82:519-522.
27. Pollick C, Hale SL, Kloner RA. Echocardiographic and cardiac Doppler assessment of mice. J Am Soc Echocardiogr. 1995;8:602-610.